# Gemini Pharmaceuticals, Inc. – FDA Inspection, Sep 7, 2012

Source: https://www.keypedia.com/records/fda_inspections/gemini-pharmaceuticals-inc/8ccd38c4-b04f-4a2f-a1ab-040379671397
Source feed: FDA_Inspections

> FDA inspection 804876 of Gemini Pharmaceuticals, Inc., September 07, 2012. Classification: No Action Indicated (NAI). 9 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 804876
- Company Name: Gemini Pharmaceuticals, Inc.
- Inspection Date: 2012-09-07
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1317530 - 2026-05-15](https://www.keypedia.com/records/fda_inspections/gemini-pharmaceuticals-inc/3c2276f9-a20a-4803-a2e7-9277b1bf2a74)
- FDA Inspection 1175407 - 2022-07-26
- FDA Inspection 1064447 - 2018-08-23
- [FDA Inspection 1041525 - 2018-02-16](https://www.keypedia.com/records/fda_inspections/gemini-pharmaceuticals-inc/5f815dde-5720-44ae-a6e5-ab350f64a85e)
- [FDA Inspection 936886 - 2015-06-30](https://www.keypedia.com/records/fda_inspections/gemini-pharmaceuticals-inc/6d577591-8391-4524-a2b4-21427df5636b)

Company: https://www.keypedia.com/companies/gemini-pharmaceuticals-inc/9e83f65c-3863-4ad6-a434-b37d9673ac0f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c